- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Cancers Expressing HER-2 and/or CEA
Total 2398 results
-
Mersana TherapeuticsRecruitingHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Non-Small Cell Lung Cancer | HER2-positive Colorectal Cancer | HER2-positive Tumors | HER2 Low Breast CancerUnited States
-
Japan Breast Cancer Research GroupChugai PharmaceuticalUnknownHER2-positive Locally Advanced or Metastatic Breast CancerJapan
-
Samsung Bioepis Co., Ltd.CompletedHER2 Positive Early or Locally Advanced Breast CancerCzechia
-
Istituto Oncologico Veneto IRCCSAssociation for Translational Research in Oncology (AS.T.R.O.)CompletedEndocrine Sensitive HER2+/HR+ Breast CancerItaly
-
AstraZenecaCompletedAdvanced or Metastatic Breast Cancer | ER+ve Advanced or Metastatic Breast CancerCanada, France, Korea, Republic of, Czechia, Peru, United Kingdom, Spain, Japan, Mexico, Singapore, Bulgaria
-
Abramson Cancer Center at Penn MedicineRecruitingBreast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | ER Positive Breast CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); Syndax PharmaceuticalsTerminatedBreast Cancer | Invasive Breast Cancer | ER-Negative PR-Negative HER2-Negative Breast CancerUnited States
-
University Hospital, Gentofte, CopenhagenCompletedDiabetes Mellitus, Type 2 | Hydroxymethylglutaryl-CoA Reductase InhibitorsDenmark
-
Sarah Sammons, MDDaiichi SankyoRecruitingBreast Cancer | Breast Cancer Female | Metastatic Triple-Negative Breast Carcinoma | HER2-negative Breast Cancer | HER2 Negative Breast Carcinoma | ER-negative Breast Cancer | ER Positive Breast CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingHER2-PositiveRecurrent or Metastatic Breast Cancer
-
AdaptimmuneActive, not recruitingHepatocellular Cancer | AFP Expressing TumorsUnited States, United Kingdom, France, Spain
-
Zhejiang Cancer HospitalRecruitingAdvanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment FailedChina
-
University Hospital, AkershusVestre Viken Hospital Trust; NovartisRecruitingBreast Cancer | Locally Advanced Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | Luminal A Breast Cancer | Luminal B Breast CancerNorway
-
Zhejiang Cancer HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.Not yet recruitingFemale Breast Cancer Patients | Histopathologically Confirmed Advanced HR +/HER2-invasive Breast Cancer | HRD Positive Advanced Breast Cancer
-
UNC Lineberger Comprehensive Cancer CenterNovartis PharmaceuticalsCompletedHER-2 Positive Breast CancerUnited States
-
AstraZenecaRecruitingER+ HER2- Advanced Breast Cancer | High-grade Serous Ovarian Cancer (HGSOC)United Kingdom, Korea, Republic of, Australia, United States, Spain
-
National Taiwan University HospitalCompletedDiabetes and Healthy Control | FTO Gene Expression | Aerobic Exercise Intervention or Home Exercise | Pre-training and Post-trainingTaiwan
-
OncoSec Medical IncorporatedCompletedER-Negative PR-Negative HER2-Negative Breast CancerUnited States
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerUnited States, Italy, Korea, Republic of, Canada, Germany, United Kingdom, Australia, Belgium, Brazil, China, Denmark, France, Hong Kong, Portugal, Spain, Taiwan, Turkey, Japan, Argentina, Mexico, Israel, Poland, Russian Federation, A... and more
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerUnited States, Korea, Republic of, China, Poland, Taiwan, Turkey, United Kingdom, Australia, Argentina, Germany, Singapore, Thailand, Israel, Russian Federation, Ukraine, Brazil, South Africa
-
Massachusetts General HospitalPuma Biotechnology, Inc.; Celcuity, Inc.WithdrawnMetastatic Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast Cancer | PR-Positive Breast Cancer | Stage IV (Metastatic) Breast CancerUnited States
-
Massachusetts General HospitalGilead SciencesRecruitingTriple Negative Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast CancerUnited States
-
Merrimack PharmaceuticalsSanofiCompletedER Positive, Her2 Negative Breast Cancer Patients | Triple Negative Breast Cancer PatientsUnited States
-
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.RecruitingTriple-negative Breast Cancer and HR+/HER2- BCChina
-
Queen Fabiola Children's University HospitalCenter of Human Genetics - ULB in Brussels; Interuniversity Institute of Bioinformatics...UnknownGenodermatosis | Rare Genetic Disease With Cutaneous ExpressionBelgium
-
Gilead SciencesRecruitingStudy of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors (ASCENT-J02)Advanced Solid Tumor | Metastatic Urothelial Cancer | Metastatic Triple-Negative Breast Cancer | HR+/HER2- Metastatic Breast CancerJapan
-
Amsterdam UMC, location VUmcUnknownNSCLC | EGFR-mutation | HER2-expressionNetherlands
-
SanofiUNC Lineberger Comprehensive Cancer CenterCompletedBrain Metastases | Estrogen Receptor Negative (ER-Negative) Breast Cancer | Progesterone Receptor Negative (PR-Negative) Breast Cancer | Human Epidermal Growth Factor Receptor 2 Negative (HER2-Negative) Breast CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingHER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and TaxaneChina
-
Royal Marsden NHS Foundation TrustPfizer; Breast Cancer NowRecruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | Recurrent Breast Cancer | ER+ Breast CancerUnited Kingdom
-
Laura M. Spring, MDMerck Sharp & Dohme LLC; Translational Breast Cancer Research Consortium; Breast...RecruitingTriple Negative Breast Cancer | Hormone Receptor Positive (HR+), HER2-negative Breast Cancer | Biopsy-proven, Positive Lymph Node(s)United States
-
Blokhin's Russian Cancer Research CenterRussian Society of Clinical OncologyCompletedMetastatic Disease | HR+/HER2- Breast Cancer | Аdvanced DiseaseRussian Federation
-
Novartis PharmaceuticalsTerminatedAdvanced or Metastatic ER+ Breast CancerUnited States, France, Germany, Singapore, Italy, Japan, Belgium
-
Riphah International UniversityCompletedStroke (CVA) or TIAPakistan
-
German Breast GroupRoche Pharma AG; Celgene CorporationCompletedInflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IVGermany
-
German Breast GroupGlaxoSmithKline; Roche Pharma AG; Teva Pharmaceuticals USACompletedInflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IVGermany
-
Dana-Farber Cancer InstitutePfizerCompletedHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor (HR)-Positive Breast CancerUnited States
-
Ontario Clinical Oncology Group (OCOG)Cancer Care OntarioCompletedStage III Breast Cancer (T0N2, T1N2, T2N2, T3N1, 2 or T4) | Stage IIb Breast Cancer (T3N0)Canada
-
Novartis PharmaceuticalsNo longer availableHR+ Advanced or Metastatic Breast Cancer
-
Seagen Inc.CompletedHER2 Positive Metastatic Breast CancersUnited States
-
Daiichi SankyoRecruitingBreast Cancer | Advanced Cancer | HER2-positive Breast Cancer | HER2-low Breast CancerChina
-
Centre Hospitalier Universitaire de NiceRecruiting
-
Chinese University of Hong KongRecruiting
-
Montefiore Medical CenterWithdrawnStroke (CVA) or TIA
-
Chongqing University Cancer HospitalNot yet recruitingCervical Cancer | Ovarian Cancer | Endometrial Cancer | HER2 Expression
-
Cancer Trials IrelandCompletedBreast Cancer | HER2 Positive Breast Cancer | HER2 Negative Breast CancerIreland
-
University of MalayaPfizer; Cancer Research Malaysia; Pantai Hospital Kuala Lumpur; Hospital Sultan...RecruitingTriple Negative Breast Cancer | HRD 100 Gene Expression HighMalaysia
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedHER2/Neu Negative | Stage IV Breast Cancer AJCC v6 and v7 | Estrogen Receptor and/or Progesterone Receptor PositiveUnited States
-
GeneQuantum Healthcare (Suzhou) Co., Ltd.RecruitingHER2-positive Breast Cancer | HER2-positive Biliary Tract Cancer | HER2-Positive Salivary Gland Carcinomas | HER2-Positive Advanced Solid TumorChina, Australia, United States
-
Korea University Guro HospitalCompletedExpression of Integrin ανβ3 in Lung CancerKorea, Republic of